Nauru vs Naoero: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Nauru
0.6%
in 2024
Naoero
0.6%
in 2024
Nauru rank
60th
Naoero rank
60th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Nauru
- Naoero
How they compare
Nauru currently reports 0.6% against 0.6% in Naoero, a difference of 0.0%.
Across all 10 years both countries report, Naoero has been ahead every year.
Nauru ranks 60th and Naoero ranks 60th of 247 countries.
Head to head by decade
| Decade | Nauru | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.2% | 1.2% | 0.0% | — |
| 2020s | 0.7% | 0.7% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Nauru or Naoero?
- Nauru, at 0.6% against 0.6% in Naoero as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Nauru and Naoero?
- 0.0%, with Nauru ahead.
- How many years of comparable data are there for Nauru and Naoero?
- 10 years are reported by both, from 2015 to 2024.
- How do Nauru and Naoero rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Nauru ranks 60th and Naoero ranks 60th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.